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ABSTRACT 
AN IN VITRO CYTOTOXICITY STUDY OF 
GLUTARALDEHYDE AND NO- REACT® TREATED 
BIOPROSTHETIC HEART VALVES AND THE AORTIC WALL 
by 
Roger Ongosi 
Valvular failure due to calcification and leaflet disruption of artificial bioprostheses is still 
a major concern in valve replacement surgery. Previous studies have shown that 
Glutaraldehyde, a chemical used in the treatment of artificial valves promotes calcification. 
In this investigation glutaraldehyde and No-React® treated tissue samples of pericardium, 
cusp and the aortic wall were tested for cytocompatibility using live mouse fibroblast 
cultures. The samples were cut into 3 X 3 mm2 washed in phosphate buffered saline 
solution, transferred into cell culture flask containing cells that had been cultured for 24 
hours and incubated at 37 "C in 5 % CO2  Cell viability was monitored after 24 hours by 
dye exclusion method. The concentration of glutaraldehyde released from the tissues was 
monitored by incubating 3 X 3 mm2 glutaraldehyde treated tissue samples in cell culture 
media at 37 "C and 5 % CO2. The media was then analyzed for glutaraldehyde using 
UV/Visible spectrometer. The toxic levels of glutaraldehyde was monitored by •first 
incubating the cell for 24 hours in cell culture media at 37 "C and 5 % CO2 and then 
injecting various know concentrations of standard glutaraldehyde and the viability 
monitored by use of dye exclusion method. 
Experimental results showed that detoxified (No-React®) pericardium and cusp from 
Shelhigh Inc. had the highest cytocompatibility as compared to the aortic wall. There was 
high cell mortality in glutaraldehyde treated tissues and most of the cell die close to the 
tissue. They also show that glutaraldehyde concentrations less than 10 ppm does not have 
significant cell mortality. No glutaraldehyde was detected from the tissues tested for its 
release. 
From the results it can be concluded that glutaraldehyde is one, but not the only factor 
responsible for cell death in fibroblast culture and that the aortic wall is much more 
difficult to detoxify as compared to pericardium and cusp. Lack of high glutaraldehyde 
release from incubated tissue and high cell mortality closer to the tissue shows that surface 
toxicity may play a part in cell mortality. 
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CHAPTER I. 
INTRODUCTION 
1.1 Objective 
The objective of this thesis is to try and understand the factors responsible for valvular 
heart failure by: 
• studying the mechanism of cell death in in-vitro fibroblast culture. 
• studying the rate of glutaraldehyde release from conventionally treated animal tissues. 
• investigating the influence of glutaraldehyde concentrations on the viability of the cells 
in the culture. 
• investigating possible other factors responsible for cell death in the culture media, in 
the presence of conventionally treated tissue or detoxified tissues. 
1.2 Background Information 
The heart valves open and close in response to cyclical changes in intra-cardiac and 
arterial pressures. This directs the cardiac output forward into the pulmonary and systemic 
circulation without impending flow, Valvular heart disease adversely affects ventricular 
loading and tends to diminish cardiac output. Obstruction of forward (stenosis) or 
regurgitation of flow at any of the four heart valves is considered to be valvular heart 
disease. Malfunction of the valves is much more common on the left side of the heart than 
the right side.[1] Inadequate performance of the left pump results in pulmonary 
congestion, a reduced cardiac output and increased volume and pressure in the left atrium 
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and pulmonary vasculature, Whereas inadequate performance of the right pump leads to 
systemic congestion, a reduced cardiac output and increased volume and pressure in the 
right atrium and systemic venous system. 
	
This dysfunction commonly leads to heart 
failure, although compensatory mechanisms will often preserve haemodynamic stability. 
Surgery has revolutionized the management of valvular heart disease and can produce 
close to complete haemodynamic correction. The timing of valve surgery being very 
important. If it is delayed until ventricular dysfunction or pulmonary hypertension has 
become irreversible, the risks are greater and the results less satisfactory. In most cases 
surgical correction requires replacement of the valve with a tissue graft or a mechanical 
prostheses. 
Glutaraldehyde is the standard reagent for the modification of fresh bioprosthetic leaflet 
materials. It reacts effectively with collagen-based biomaterials, cross-linking the 
molecules via amino groups, and reduces the antigenicity of the materials. Glutaraldehyde 
preserved bioprosthetic heart valves are widely used to replace the diseased human heart 
valves. A large proportion of patients receiving these bioprostheses do not require long-
term anti-coagulation therapy. However, the long term function and durability of these 
valves is far from ideal. There are many clinical studies reporting valve failure [2], [3], but 
very few studies have been made of the different types of failure modes and the influence 
of valve design and biological processes on the mechanism of failure. For the past three 
decades the clinical reality of cardiac valve, continued improvement in design and 
fabrication of mechanical and biological valve prostheses that have led to improved 
hemodynamics and durability. 
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The two most important causes of valve failure are reported as calcification and leaflet 
disruption. The most common being calcification [4]. The No-React anticalcification 
treatment has been reported as the ideal treatment for bioprostheses and acts to prevent 
adhesions, thrombosis and calcification in animals. [5]. The precise mechanism of 
calcification is not known, although Glutaraldehyde has been implicated as a promoter of 
the calcification process. Previous studies done at UMDNJ cardiovascular laboratory have 
shown a direct correlation between calcification and cytocompatibility of the different 
tissues treated with glutaraldehyde only or detoxified with the No-React® process. Cell 
death in the cytocompatibility tests is thought to be associated to a release of 
glutaraldehyde from the tissue when introduced into the cell culture. In this study we have 
investigated the mechanisms of cell death, the rate of glutaraldehyde release from 
conventionally treated tissues and the influence of glutaraldehyde concentration on the 
viability of the cells in the culture. Cytocompatibility tests done today on glutaraldehyde 
treated tissues considers 70 % cell viability of the cells after 24 hours as good, while 
Shelhigh consider excellent cytocompatibility to have viability of 95 % or close to 95 % 
or both. Tissue detoxification is considered by Shelhigh to be excellent if close to 100 %, 
However tissues stored in glutaraldehyde for long periods are found to be more toxic. 
Studies done with Dr. Gabbay's group have shown that the regular 15 minutes rinsing in - 
the operation room just before implanting a valve are inadequate, The studies have shown 
that glutaraldehyde continue to leach out for more than 500 hours of saline incubation. 
Studies done at Shelhigh and outside laboratory reveled that no glutaraldehyde could be 
detected from detoxified tissue. If detoxified tissue is 100 % cytocompatible and does not 
release any glutaraldehyde molecules one might conclude that the total cell viability is the 
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results of no glutaraldehyde leaching to the culture media. In this study we intended to 
identify if this assumption is correct or may be there is another factor that is responsible 
for the cell death. If glutaraldehyde is the culprit we intend to study what is the culture 
concentration that is toxic enough to cause cell death. 
CHAPTER 2 
CYTOCOMPATIBILITY TESTS 
2.1 Apparatus, Materials and Methods 
2.1.1 Apparatus and Materials 
a. Carbon dioxide Incubator (Napco® controlled automatic water jacketed CO2 incubator 
series 6301 from Precision scientific Inc. Chicago, 1L USA.) 
b. Reverse phase microscope (Olympus model CK2 from Olympus optical co. Ltd Japan.) 
c. Surgical tools 
d. Autoclave - Amsco Eagle series 3021 gravity. 
e. Filter assembly, T-25 cm2 cell culture flasks, 6-Well cell culture flasks, Bottle top filter ( 
0.2µm pore size )from Corning and supplied Fisher Scientific, Pittsburgh, PA USA. 
f. Cell culture media - Dulbecco's modified Eagle media (DMEM), pH = 7.3, Penicillin, 
Streptomycin, Fetal Bovine Serum, Non-essential Amino acids Phosphate Buffered Saline 
Water (PBS solution). Erythrocin B dye (red). Sodium bicarbonate (NaHCO3)for cell 
culture. Are all GIBCO products supplied by Life Technologies, Inc. Gaithersburg, MD 
USA. 
g. Cells -L929 cell line, Live mouse fibroblast cells. 
h. 25% Standard glutaraldehyde solution - Baker analyzed reagent for biological 
applications obtained from J. T. Baker Chemical Co. 
1. Glutaraldehyde treated tissues given by Dr. S. Gabbay. 
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2.1.2.. Preparation of Cell Culture Media 
A 3.7g of NaHCO3 was weighed into a 1-liter conical flask and DMEM powder added 
(whole pack), The pack was rinsed several times with Millipore water into the conical 
flask. The Millipore water was added to about the liter mark and the contents stirred for 
30 minutes gently to allow uniform mixing. The resulting solution was sterilized by 
filtration through a sterile cellulose acetate membrane under maximum aseptic conditions. 
To the sterized media 1 % non-essential amino acids, 10 % fetal bovine serum, 10 % 
antibiotic solution was added. This was ready for use. 
2.1.3 Cell Culture 
L-929 cell line in vials preserved under liquid nitrogen was pre-warmed by putting it in a 
water bath at 37 °C with constant shaking, it was then washed with 70 % alcohol and 
kept in a laminar flow hood where the cells were quickly transferred into the culture flask 
containing cell culture media under total aseptic conditions. All care was taken to avoid 
any contaminations. The culture was labeled and incubated in 5 % carbon dioxide at 37 
°C. After 48 hours, the cells were subcultured into 6-well culture flasks in 1 ml of fresh 
media. 
2.2. Tissue Sample Preparation and Analysis 
The tissue sample to be tested were cut into 3 x 3 mm square under laminar flow hood 
observing total aseptic conditions and washed for 30 minutes in 3 portions of each 10m1 
using sterile PBS solution. The tissues were then transferred into a 6-well culture flask 
containing cells that had been cultured for 24 hours. This was followed by incubation at 
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37 °C in 5 % carbon dioxide. After 24 hours the viability of the cells was tested by use of 
the dye exclusion method and observed under a reverse phase microscope. The number of 
stained/dead and unstained/live was counted and the result computed. 
2.2.1 Dye Application 
Erythrocin B dye is used because it only stains dead cells. Once the cells die there cell 
membrane is weakened and the dye is able to go through and stain the cells unlike the live 
cell where the membrane is still interact. To one well at a time, using a pipette the cell 
culture media was carefully removed and quickly added a few drops of erythrocin B just 
enough to cover the bottom of the well. After 10 seconds the dye was taken out using a 
pipette by tilting the well to the side and avoiding scratching the bottom of the well and 
any tissue movement. The wells were covered and the cells observed under the reverse 
phase microscope. With the help of a counter, stained cells (red) were and the unstained 
ones were counted within the grid. The grid was as close as possible or just about to touch 
the tissue. This counting was repeated all round the tissue and the average numbers 
determined. 
2.2.2 Determination of the Toxicity Levels of Glutaraldehyde 
This analysis was done in order to determine the minimum concentration of glutaraldehyde 
that can cause cell death. Glutaraldehyde (25 %) was diluted to 1.0 ppm, 5 ppm, 10 ppm, 
20 ppm and 50 ppm using cell culture media under total aseptic conditions. 1 ml of 25 % 
glutaraldehyde solution was diluted to 250 ml using cell culture media. 1 ml of fresh 
culture media was mixed with 1, 5, 10, 20, and 50 pi of this stock solution to give the I, 
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5, 10, 20, and 50 ppm solutions respectively. The live mouse fibroblasts cells were 
cultured in the 25cm2 cell culture flasks at 37 °C and 5 % carbon dioxide concentration for 
48 hours. The confluenced cells were further sub-cultured into a six well culture flask for 
24 hours after which the various glutaraldehyde concentrations prepared above were 
injected into the wells and the cells further incubated. After a period of 24 hours the % 
cell viability was monitored using a reverse phase microscope and 0.1 % erythrocin B as 
the dye. 
2.2.3 Calculations 
The % Cell viability was calculated from counts obtained for dead(stained) and live 
(unstained)cells. 
% Cell viability= 	 # of unstained cells/Total number of cells X 100 
From the results, the level of toxicity was defined. 
CHAPTER 3 
SPECTROMETRIC ANALYSIS OF 
GLUTARALDEHYDE CONCENTRATION 
3.1 Materials and Methods 
3.1.1 Materials 
Apparatus 
a. UV/Visible Recording Spectrometer Shimadzu UV160, from Shimadzu Scientific 
Instruments, Inc. Columbia. Maryland, USA. 
b. Analytical Balance - Sartorius Handy H51 from Brinkmann Instruments Co. Division of 
Sybron. Westbury, New York. 
c. Analytical Grade Methanol and 2,4-dinitrophenylhydrazine solution obtained from 
Sigma Chemical Co. MD USA 
d. 25% Standard Glutaraldehyde Aqueous Solution Baker analyzed reagent for biological 
applications, Potassium Hydroxide Pellet - food grade, Concentrated Hydrochloric Acid 
obtained from J.T. Baker Chemical Co. 
e. Phosphate Buffered Saline Water (PBS solution). GIBCO product supplied by Life 
Technologies, Inc. Gaithersburg, MD USA. 
3.1.2. Preparation of Standard Glutaraldehyde Concentrations 
200 µl of 25 % standard glutaraldehyde solution was diluted to 50 ml using methanol and 
this gave 1000 ppm glutaraldehyde solution, 1000 µl of PBS solution was mixed with 
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5 µI, 10 µ1, 15 µI and 20 µl of the 1000 ppm standard glutaraldehyde solution to give 5, 
10, 15 and 20 ppm standard glutaraldehyde solutions respectively. 
3.1.3 Preparation of 2,4-Dinitrophenylhydrazine Solution 
A saturated solution in methanol was prepared using 2,4-dinitrophenylhydrazine. To 10 ml 
of methanol in vial, 2,4-dinitrophenylhydrazine was added with stirring till saturation. This 
solution was not used more than a week or two after preparation. 
3.I.4 Preparation of Potassium Hydroxide Solution 
10 grams of potassium hydroxide was dissolved in 20 ml of distilled water and the solution 
was made up to 100 ml using methanol. This solution was kept indefinitely. 
3.1.5 Glutaraldehyde Analysis 
Analysis of the prepared standard glutaraldehyde concentrations was used in plotting of 
the standard curve. To I ml of 5 ppm, 10 ppm, 15 ppm and 20 ppm standard 
glutaraldehyde solutions in methanol, 1 ml of 2,4-dinitrophenylhydrazine solution was 
added and followed by one drop of concentrated hydrochloric acid. The vials were 
stoppered loosely and heated in a water bath at 100 °C for 5 minutes. After cooling 5 ml 
of potassium hydroxide solution was added. The almost black solution that resulted 
rapidly cleared to a characteristic wine-red color. Blank determination was simultaneously 
prepared using I ml of methanol. The absorbance of the resulting solutions were read 
using a UV/Visible Recording spectrometer. This was done at 480 nm wavelength. 
3.1.6 Influence of Glutaraldehyde Concentrations on Cell Death 
This was done in-order to investigate the if glutaraldehyde was released from the 
conventionally glutaraldehyde treated tissue and also the concentration of the 
glutaraldehyde released, Pericardium tissue samples were used because the conventionally 
glutaraldehyde treated pericardium will kill the cells. This could therefore show the factors 
responsible for the cell death, 
Glutaraldehyde treated tissue (pericardium) was cut into 3 x 3 mm2 samples and washed in 
three changes of phosphate buffered saline water for 30 minutes. This tissues were put in 1 
ml of culture media in a 6-well culture flask wells as shown in the figure 3.1 and incubated 
at 37 °C and 5 % CO2 concentration. After 24 hours the following was done. To one 
patch: 
a) One ml from post-incubation culture media was drawn and the concentration of 
glutaraldehyde analyzed using the UV/Visible Recording Spectrometer as per previously 
outlined procedures. 
b) One nil of post-incubation culture media was drawn and injected in previously cultured 
confluenced cells and the cell viability monitored using 0.1 % erythrocin B dye and a 
reverse phase microscope. 
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Figure 3.1 Cell Culture flask Showing the Position of the Tissue at the Center 
CHAPTER 4 
RESULTS 
4.1 Cytocompatibility Tests 
Glutaraldehyde and No react® treated tissues were tested for cytocompatibility. The 
conventionally glutaraldehyde treated tissue were used as a control to monitor the 
effectiveness of the No-React® detoxification process. 	 The detoxified cusps and 
pericardium from Shelhigh Inc. displayed high cytocompatibility close to or 100 % 
viability and this is considered excellent as compared to the aortic wall. The In-house 
detoxified aortic wall although known to be more difficult to detoxify, has been 
successfully detoxified although the results do not reach 100 % cytocompatibility it 
reached 93 —96 % cytocompatibility which is considered excellent as well. The aortic wall 
supplied from outside sources to Shelhigh was found to be difficult to detoxify and 
showed a viability of 63 %. This was closely followed by the aortic wall from lonescu-
Shiley which was 46 % both lower that the accepted 70 % viability as good. This forms a 
case for further investigation. The Biocor glutaraldehyde treated aortic wall was the worst 
and showed 0 % viability while the cusp had 37 % viability and this was the lowest of all 
the different tissue analyzed (Figure 4.1). The results are an average of several test done in 
a period of one year as part of the quality control. 
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4.2 Determination of the Toxicity Levels of Glutaraldehyde 
The average cell viability was calculated as shown in figure 4.2. There were no 
stained/dead cells at 1 ppm and 5 ppm solutions. At 10 ppm glutaraldehyde concentrations 
there was 5 % mortality of the cells. The viability decreased with increased glutaraldehyde 
concentrations. However, the decrease in the viability was not drastic as early though. At 
50 ppm there was 65 viability. This leaves many questions as to whether glutaraldehyde is 
the sore source of cytocompatibility. 
4.3 Spectrometric Analysis of Glutaraldehyde Concetration 
a) A test for aldehydes done of the media incubated with the tissues for 24 hours showed 
that no glutaraldehyde was released from conventionally glutaraldehyde treated tissues or 
the concentration was below the detection limit (figure 3). This clearly shows that there 
might be another factor other than glutaraldehyde that is responsible for the poor 
cytocompatibility of this tissues. Previous studies also showed that tissues conventionally 
treated with glutaraldehyde and kept in glutaraldehyde solution had high cell mortality but 
not necessarily high glutaraldehyde release. 
b) When the culture media was drawn and injected into previously cultured confluenced 
cells no cell dead was observed after 24 hours. This may be due to the absence or low 
concentration of glutaraldehyde in the media as glutaraldehyde has been shown to reduce 
cell viability. The concentration of glutaraldehyde has to be close or 10 ppm before 
significant cell mortality can be observed. The presence of the tissue may play a role in cell 
death too, because when this used tissue is incubated with fresh cells there is a substantial 
decrease in cell viability when conventionally treated tissue is put in the culture media. 
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Figure 4.1: Comparison of % Cell Viability of tissues from different manufacturers. 
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Figure 4.2 Effect of Glutaraldehyde Concetration on Cell Viability 
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Figure 4.3 Standard Glutaraldehyde Curve Showing Zero Absorbance for 
Samples Tested 
CHAPTER 5 
DISCUSSION 
Research on calcific degeneration of biological implants in the heart particularly the 
glutaraldehyde-treated bioprostheses has shown that glutaraldehyde is one of the factors 
responsible for the calcification. Cytocompatibility studies carried out on glutaraldehyde 
treated tissue has shown that there is a high cell mortality of the cells close to the tissue as 
compared to those far away from the tissue. This may be due to the release of 
glutaraldehyde from the tissues, the concentration being high close to the tissue and/or 
there might be a surface toxicity leading to a cascade phenomena. The toxicity levels of 
glutaraldehyde were found to be low. This highly supported the theory of surface toxicity 
since it was found at a concentration of 5 ppm in the solution of glutaraldehyde do we 
start seeing signs of toxicity. At 50 ppm there is still a high cell viability and this leads to 
the conclusion that there must be a additional factor "cytocompatibility factor" which is 
also responsible for the low cell viability in glutaraldehyde treated bioprostheses. This is a 
subject for future investigation. 
The cytocompatibility of various bioprostheses carried out also showed that 
glutaraldehyde treated and not-detoxified tissues from biocor had the lowest viability as 
compared to those from Shelhigh Inc (Table 5.1). The glutaraldehyde-treated detoxified 
pericardium and cusp from Shelhigh Inc. displayed the highest viability. It is interesting to 
note that tissue from Biocor conventionally treated and especially aortic wall tissue, was 
found to be toxic to the level close to 100 % death of the cells in 24 hours. It is well 
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accepted fact that aortic wall for unclear reasons is more difficult to detoxify or to treat. 
for anticalcification treatment. For example the AOA treatment, seems to work on cusp 
tissue but not at all on the aortic wall [5]. In the past SheIhigh. detoxified tissue for Biocor 
(Belo Horizonte, Brazil) showed very high cell viability in cell cultures, while cusps and 
pericardium gave excellent results and aortic wall gave less than adequate results 
( between 30 — 60 % cell viability ). Aortic wall treated at Shethigh with the conventional 
method then detoxified resulted in an excellent detoxification (92 — 96 % cell viability) 
There is no clear explanation as to why the aortic wall of one manufacturer is difficult to 
detoxify while others can be detoxified more readily. More testing should be done to 
elucidate the aortic wall behavior as a calcification enhancement. 
This investigation clearly showed that the reason for cell death is not necessarily 
glutaraldehyde release, since we could not detect sufficient amount in the cell culture 
media. The question is what exactly is the factor responsible for the cell death? It could be 
a chemical factor of unknown origin, but it could also be that the direct contact of the cells 
with the tissue that is treated on it's surface has glutaraldehyde molecules causing the cell 
to die and the dead cells change the pH of the solution (p1-I measurements clone by Dr. 
Gabbay's group shows that the pH is reduced from 7.4 to 3 or 4 ) If enough cells on 
contact with the tissue die, then there will be enough tissue destruction to lower the p1-1 
which can cause cell death practically a dominant effect. More studies should be 
performed to give credence to the theory. It could also be that the detoxification process 
can also inhibit or clear a chemical factor that might be responsible to the cell death. More 
research is required to investigate Ibis subject, since it has a direct clinical application. The 
No-React® detoxification process seem to change the characteristics of the tissue which 
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result to uniqueness of the tissue, long term clinical follow up and studies are needed to 
confirm all these interesting in-vitro results. 
Table 5.1 The % Cell Viability for Different Animal Tissues Tested 
COMPATIBILITY STUDIES 
Tissue Sample 
Lot Number 
Sample Description % Cell 
Viability 
971010 SHP Pericardiurn NR BOH 99 
971010 SHP Aortic wall NR-BOH 86 
971010 SHP Cusp NR-BOH 98 
971010 SHP Pericardium NR BOH 98 
971010 SHP Aortic wall NR-BOH 94 
971024 - Pericardium Glut rx BOH 63 
YSP-1-0409-10 lonescu-Shiley 4% glut. 46 
971117-Ts Pericardium NR BOH 96 
970925 SHP Pericardium NR BOH 97.5 
971008 SHP Pericardium NR BOH 97.5 
970421 A Shelhigh Aortic Wall NR BOH 88.3 
970807 - SHP Pericardium Patch 90.5 
940901 II Pericardium OH small 92.8 
970929 - A Aortic wall NR-BOH 93 
970929 -A Cusp No-React 98 
970929 -A Bovine mammary vessel NR BOH 97 
970929 -A Bovine mammary vessel NR BOH 94 
970929 SHP Pericardium NR BOH 99 
971010 SHP Pericardium NR BOH 99 
971010 A Aortic Wall NR BOH 86 
971010 A Cusp NR BOH 98 
971010 SHP Pericardium NR BOH 98 
971010 A Cusp NR BOH 99 
971010 A Aortic wall NR BOH 94 
960215 A Biocor Glut. Aortic wall 0 
960215 A Biocor glut. Cusp 37 
960401 II Biocor Glut. Pericardium 3.2 
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